🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMASH prevalence in GLP-1 users — 6 month update Page 3

MASH prevalence in GLP-1 users — 6 month update

CryptoCarl Tue, Sep 24, 2024 at 4:37 PM 12 replies 1,822 viewsPage 3 of 3
DanielChem_CHI
Senior Member
1,234
5,678
Mar 2024
Chicago, IL
Sep 25, 2024 at 5:46 AM#11
sophie_paris said:
It is worth asking what the claim would look like if it were false.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

20 18fiona_VT, denise_HTX, raj_cambridge and 17 others
Reply Quote Save Share Report
hans_munich
Member
534
2,345
Jul 2024
Munich, DE
Sep 25, 2024 at 10:14 AM#12
fiona_glasgow said:
Liver imaging follow-up for liver and MASH: FibroScan at baseline showed CAP score 315 dB/m (moderate steatosis) and stiffness 8.8 kPa (possible…

Genuinely useful, thank you. I had the facts and not the framework. Sending this to two other people who asked me the same thing last week.

Last edited: Sep 25, 2024 at 4:14 PM
21 19alex_tucson, kevin_tulsa, Dr.PainCLE and 18 others
Reply Quote Save Share Report
mike_mealprep
Member
412
1,890
Jul 2024
Chicago, IL
Sep 25, 2024 at 2:42 PM#13
sophie_paris said:
It is worth asking what the claim would look like if it were false.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

22 20Dr.AddMedPHL, newstart_MO, mia_MS2 and 19 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Sep 25, 2024 at 7:10 PM#14

Adding the numbers, since they settle part of this. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

23 21FranDenver, Dr.BariatricHTX, LindaRN_retired and 20 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Sep 25, 2024 at 11:38 PM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

Last edited: Sep 26, 2024 at 1:38 AM
24 22PurityPaulOR, MaxMetOK, MounjBrad and 21 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register